Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

被引：0
|
作者：
Clive Ballard
J. M. Youakim
B. Coate
S. Stankovic
机构：
[1] University of Exeter Medical School,Institute of Health Research
[2] ACADIA Pharmaceuticals Inc.,undefined
来源：
The Journal of Prevention of Alzheimer's Disease | 2019年 / 6卷
关键词：
Pimavanserin; Alzheimer’s disease; psychosis; severe;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 33
页数：6
相关论文
共 50 条
  • [41] Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease
    Levy, ML
    Cummings, JL
    Fairbanks, LA
    Bravi, D
    Calvani, M
    Carta, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (11): : 1438 - 1443
  • [42] Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease
    McLachlan, Emma
    Bousfield, Jennifer
    Howard, Robert
    Reeves, Suzanne
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (02) : 389 - 395
  • [43] Long-term efficacy of olanzapine in the control of psychotic and behavioural symptoms in patients with Alzheimer's dementia
    Street, JS
    Clark, WS
    Juliar, BE
    Feldman, PD
    Kadam, DL
    Breíer, A
    EUROPEAN PSYCHIATRY, 2000, 15 : 346S - 347S
  • [44] Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia
    Street, JS
    Clark, WS
    Juliar, BE
    Feldman, PD
    Kadam, DL
    Breier, A
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 246 - 246
  • [45] Long-term efficacy of olanzapine in the control of psychotic and behavioural symptoms in patients with Alzheimer's dementia
    Street, JS
    Clark, WS
    Juliar, BE
    Feldman, PD
    Kadam, DL
    Breier, A
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 162S - 162S
  • [46] Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease
    Siddique, Haroon
    Hynan, Linda S.
    Weiner, Myron F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 915 - 918
  • [47] Spontaneous extrapyramidal symptoms in patients with Alzheimer's disease, major depressive disorder, and psychotic disorders
    Sweet, RA
    Akil, M
    Mulsant, BH
    Pasternak, RE
    Zubenko, GS
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 4 (04): : 380 - 381
  • [48] Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis
    Sarva, Harini
    Henchcliffe, Claire
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (06) : 462 - 473
  • [49] Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
    Moreno, Gabriel M.
    Gandhi, Rhea
    Lessig, Stephanie L.
    Wright, Brenton
    Litvan, Irene
    Nahab, Fatta B.
    NEUROLOGY, 2018, 91 (17) : 797 - 799
  • [50] Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin
    Lyons, Kelly E.
    Pahwa, Rajesh
    Hermanowicz, Neal
    Davis, Thomas
    Pagan, Fernando
    Isaacson, Stuart
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (07) : 681 - 691
12345